In this study, we demonstrated that using a ghrelin receptor antagonist restored pancreatic insulin secretion and improved circulating levels that, in turn, inhibited the ethanol-induced increases in the adipose-derived serum FFA and hepatic fat dysregulation to ultimately prevent alcoholic hepatic steatosis. Here, INS is linked to Hepatic steatosis.